MedPath

Assessment of efficacy of antiseptic rinse on tongue decontamination in reducing the SARS CoV-2 community transfer.

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/07/035064
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients with positive RT PCR and reported immediately after becoming symptomatic.

2)Patients with positive RT PCR without any other underlying systemic illness.

3)Mild symptomatic under home/quarantine center isolation.

4) Age: >18 years

Exclusion Criteria

1)Pregnancy and lactating mothers.

2)Patients with any other systemic illness

3)Vaccinated with COVID 19 vaccine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness Of 0.2% Chlorhexidine, 0.5% Povidone iodine, 1.5% hydrogen peroxide mouth rinse on SARS CoV-2 community transfer.Timepoint: At the baseline, one week, end of second week.
Secondary Outcome Measures
NameTimeMethod
Comparing the effectiveness of 0.2% Chlorhexidine, 0.5% Povidone iodine, 1.5% Hydrogen Peroxide mouth rinse and saline with each other.Timepoint: At the baseline, one week and end of second week.
© Copyright 2025. All Rights Reserved by MedPath